Nur Ink Innovations (XTAE:NURI) EBITDA Margin %: 0.00% (As of . 20)


XTAE:NURI Nur Ink Innovations Ltd XTAE:NURI
24 GF Score
Price ₪8.26
! 1 Warning Sign
View Full Analysis

What is Nur Ink Innovations EBITDA Margin %?

Nur Ink Innovations XTAE:NURI +3.80% 24 EBITDA Margin % is 0.00% as of . 20. GuruFocus rates XTAE:NURI with a GF Score™ of 24/100. The stock has 1 warning sign investors should review. Among 1,580 Chemicals companies, Nur Ink Innovations ranks worse than 63291.08% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Nur Ink Innovations's EBITDA for the six months ended in . 20 was ₪0.00 Mil. Nur Ink Innovations's Revenue for the six months ended in . 20 was ₪0.00 Mil. Therefore, Nur Ink Innovations's EBITDA margin for the quarter that ended in . 20 was 0.00%.

Nur Ink Innovations  (XTAE:NURI) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Nur Ink Innovations EBITDA Margin % Related Terms

Nur Ink Innovations EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Nur Ink Innovations's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nur Ink Innovations EBITDA Margin % Chart

Nur Ink Innovations Annual Data
Trend
EBITDA Margin %

Nur Ink Innovations Semi-Annual Data
EBITDA Margin %

XTAE:NURI vs LIN, SHW, ECL: EBITDA Margin % Comparison

For the Specialty Chemicals subindustry, Nur Ink Innovations's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nur Ink Innovations EBITDA Margin % vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Nur Ink Innovations's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Nur Ink Innovations's EBITDA Margin % falls into.


XTAE:NURI
24GF Score
Nur Ink Innovations Ltd XTAE:NURI
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nur Ink Innovations EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Nur Ink Innovations's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

Nur Ink Innovations's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Nur Ink Innovations (XTAE:NURI) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nur Ink Innovations and its competitors. According to the industry distribution chart, Nur Ink Innovations ranks #999999 out of 1580 companies in the Chemicals industry.
Is Nur Ink Innovations' EBITDA Margin % too high?
Nur Ink Innovations' current EBITDA Margin % is 0.00%. Based on the distribution chart, Nur Ink Innovations ranks #999999 out of 1580 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Nur Ink Innovations has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Nur Ink Innovations' EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Nur Ink Innovations ranks #999999 out of 1580 companies for EBITDA Margin %. This places Nur Ink Innovations in the lower half of its industry. The industry median EBITDA Margin % is 9.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.63, based on 1,580 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nur Ink Innovations and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nur Ink Innovations's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nur Ink Innovations stock overvalued right now?
Nur Ink Innovations (XTAE:NURI) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Nur Ink Innovations' overall GF Score™ is 24/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Nur Ink Innovations (XTAE:NURI), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nur Ink Innovations Business Description

Address 20, Hamelacha Street, Afek Industrial Park Rosh, Ha’Ayin, ISR, 4809154
Nur Ink Innovations Ltd is engaged in the research and development of water-based inks for digital printers. Some of the products of the company are Direct-to-Garment (DTG), Direct-to-Textile (DTT), Roll-to-roll printing of indoor & outdoor advertising, and wallpapers.
24GF Score

Get the complete analysis for XTAE:NURI

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪8.26
Price